Skip to main content
OpenTrials

Clinical trial condition

Skin Diseases, Papulosquamous

Explore clinical trials studying Skin Diseases, Papulosquamous. Study availability and eligibility vary by location and protocol.

1,740 public trials 205 recruiting studies
Refine in advanced search Browse all conditions

Skin Diseases, Papulosquamous trial results

Completed

Study of the Efficacy of Early Intervention With Secukinumab 300 mg s.c. Compared to Narrow-band UVB in Patients With New-onset Moderate to Severe Plaque Psoriasis

NCT03020199

Conditions
Plaque Psoriasis, Psoriasis, Skin Diseases, +2 more
Locations
  • Novartis Investigative Site Ciudad Autonoma de Bs As, Buenos Aires, Argentina
  • Novartis Investigative Site Buenos Aires, Argentina
  • Novartis Investigative Site Pleven, Bulgaria
  • Novartis Investigative Site Plovdiv, Bulgaria
View all 44 locations
View Trial Details
Completed

To Evaluate the Efficacy and Safety of AK111 Injection in the Treatment of Moderate to Severe Plaque Psoriasis

NCT06061471

Conditions
Psoriasis, Skin Diseases, Skin Diseases, Papulosquamous, +1 more
Locations
  • The First Affiliated Hospital of Bengbu Medical College Bengbu, Anhui, China
  • The First Affiliated Hospital of Wannan Medical College Wuhu, Anhui, China
  • Affiliated Hospital of Chengde Medical University Chengde, Hebei, China
  • Nanyang First People's hospital national third class a hospital Nanyang, Henan, China
View Trial Details
Completed

Efficacy and Safety Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis

NCT03701763

Conditions
Psoriasis, Skin Diseases, Skin Diseases, Papulosquamous, +1 more
Locations
  • University of Alabama Birmingham Birmingham, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Johnson Dermatology Clinic Fort Smith, Arkansas, United States
  • Zenith Research Inc. Beverly Hills, California, United States
View all 99 locations
View Trial Details
Completed

A Study to Investigate ABP 654 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis

NCT04607980

Conditions
Plaque Psoriasis, Psoriasis, Skin Diseases, +2 more
Locations
  • Total Skin and Beauty Dermatology Center PC Birmingham, Alabama, United States
  • Alliance Dermatology and Mohs Center Phoenix, Arizona, United States
  • First OC Dermatology Fountain Valley, California, United States
  • University Clinical Trials, Inc. San Diego, California, United States
View all 84 locations
View Trial Details
Completed

A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )

NCT03047395

Conditions
Psoriasis, Skin Diseases, Skin Diseases, Papulosquamous, +1 more
Locations
  • Total Skin and Beauty Dermatology Center /ID# 154000 Birmingham, Alabama, United States
  • University of Alabama at Birmingham - Main /ID# 153983 Birmingham, Alabama, United States
  • NW Arkansas Clinical Trials Center /ID# 154014 Rogers, Arkansas, United States
  • Bakersfield Derma & Skin Cance /ID# 154008 Bakersfield, California, United States
View all 233 locations
View Trial Details

Related conditions